newsfilter
← Latest News
PR Newswire·

Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...